SLC5A2 and diabetes mellitus: Most of the included randomized clinical trials were performed in the late 1990s and early 2000s, and it is questionable whether statins will have any all-cause mortality benefits in the contemporary era with more advanced medications for diabetes mellitus, such as sodium-glucose cotransporter-2 inhibitors.